Santen Pharmaceutical Co Ltd
TSE:4536
Santen Pharmaceutical Co Ltd
EPS (Diluted)
Santen Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Santen Pharmaceutical Co Ltd
TSE:4536
|
EPS (Diluted)
¥72
|
CAGR 3-Years
46%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥92
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥104
|
CAGR 3-Years
39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
2%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥198
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
6%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥9
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-14%
|
See Also
What is Santen Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
72.6
JPY
Based on the financial report for Mar 31, 2024, Santen Pharmaceutical Co Ltd's EPS (Diluted) amounts to 72.6 JPY.
What is Santen Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%
The average annual EPS (Diluted) growth rates for Santen Pharmaceutical Co Ltd have been 46% over the past three years , -2% over the past five years , and 5% over the past ten years .